3 Patents
- US125826482026Method for Treating Central Nervous System Disorders Using Dopamine D3 Partial Agonists
BIOPROJET PHARMA
0 cites - US121346082024Benzimidazole Derivatives as Dual Histamine H1 and Histamine H4 Receptor Ligands
BIOPROJET
0 cites - US120594162024Combinations of a H3 Antagonist and a Noradrenaline Reuptake Inhibitor, and the Therapeutical Uses Thereof
BIOPROJET
0 cites